一般の方へ

心房細動と心原性脳塞栓症

お知らせ
研究班連絡先

研究班連絡先

代表:奥村 謙
事務局:富田 泰史

〒036-8562
青森県弘前市在府町5

弘前大学大学院医学研究科
循環器腎臓内科学講座

TEL: 0172-39-5057
FAX:0172-35-9190
E-mail:
ninaika@hirosaki-u.ac.jp

班研究成果

【研究成果(本研究成果の外部への発表)】

(1) 学会誌・雑誌等における論文一覧
  1. Shiroto H, Tomita H, Hagii J, Metoki N, Fujita A, Kamada T, Takahashi K, Saito S, Sasaki S, Hitomi H, Seino S, Baba Y, Uchizawa T, Iwata M, Matsumoto S, Yasujima M, Okumura K. Impact of Atrial Natriuretic Peptide Value for Predicting Paroxysmal Atrial Fibrillation in Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2017, 26, 772-778. doi:10.1016/j.jstrokecerebrovasdis.2016.10.016.
  2. Nishizaki K, Itoh T, Kimura M, Tsushima Y, Shoji Y, Kinjo T, Ishida Y, Sasaki K, Horiuchi D, Sasaki S, Tomita H, Okumura K. Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants. J Cardiol. 2017, 70, 86-91. doi:10.1016/j.jjcc.2016.10.001.
  3. Kushimoto S, Fukuoka T, Kimura A, Toyoda K, Brainsky A, Harman A, Chung T, Yasaka M. Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study. Int J Hematol. 2017, 106, 777-786. doi:10.1007/s12185-017-2311-4.
  4. Takasugi J, Yamagami H, Noguchi T, Morita Y, Tanaka T, Okuno Y, Yasuda S, Toyoda K, Gon Y, Todo K, Sakaguchi M, Nagatsuka K. Detection of Left Ventricular Thrombus by Cardiac Magnetic Resonance in Embolic Stroke of Undetermined Source. Stroke. 2017, 48, 2434-2440. doi:10.1161/STROKEAHA.117.018263.
  5. Yasaka M, Brainsky A, Toyoda K. Prothrombin Complex Concentrate for Vitamin K Antagonist-Associated Intracranial Hemorrhage - Global Evidence and the Japanese Perspective. Circ J. 2017, 81, 1564-1573. doi:10.1253/circj.CJ-17-0428.
  6. Yoshimura S, Sato S, Todo K, Okada Y, Furui E, Matsuki T, Yamagami H, Koga M, Takahashi JC, Nagatsuka K, Arihiro S, Toyoda K. Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) Study Investigators. Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study. J Neurol Sci. 2017, 375, 150-157. doi:10.1016/j.jns.2017.01.041.
  7. Inohara T, Kimura T, Ueda I, Ikemura N, Tanimoto K, Nishiyama N, Aizawa Y, Nishiyama T, Katsumata Y, Fukuda K, Takatsuki S, Kohsaka S. Effect of Compliance to Updated AHA/ACC Performance and Quality Measures Among Patients With Atrial Fibrillation on Outcome (from Japanese Multicenter Registry). Am J Cardiol. 2017, 120, 595-600. doi:10.1016/j.amjcard.2017.05.029.
  8. Liu L, Ebana Y, Nitta J, Takahashi Y, Miyazaki S, Tanaka T, Komura M, Isobe M, Furukawa T. Can. Genetic variants associated with susceptibility to atrial fibrillation in Japanese population. J. Cardiol. 2017, 33, 443-449. doi:10.1016/j.cjca.2016.10.029.
  9. Low SK, Takahashi A, Ebana Y, Ozaki K, Christophersen IE, Ellinor PT, AFGen Consortium, Ogishima S, Yamamoto M, Satoh M, Sasaki M, Yamaji T, Iwasaki M, Tsugane S, Tanaka K, Naito M, Wakai K, Tanaka H, Furukawa T, Kubo M, Ito K, Kamatani Y, Tanaka T. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population. Nat. Genet. 2017, 49, 953-958. doi:10.1038/ng.3842.
  10. Zaw KTT, Sato N, Ikeda S, Thu KS, Mieno MN, Arai T, Mori S, Furukawa T, Sasano T, Sawabe M, Tanaka M, Muramatsu M. Association of ZFHX3 gene variation with atrial fibrillation, cerebral infarction, and lung thromboembolism: An autopsy study. J. Cardiol. 2017, 70, 180-184. doi:10.1016/j.jjcc.2016.11.005.
  11. Ebana Y, Ozaki K, Liu L, Hachiya H, Hirao K, Isobe M, Kubo M, Tanaka T, Furukawa T. J. Clinical utility and functional analysis of variants in atrial fibrillation-associated locus 4q25. Cardiol. 2017, 70, 366-373. doi:10.1016/j.jjcc.2016.11.016.
  12. Miyazaki S, Ebana Y, Liu L, Nakamura H, Hachiya H, Taniguchi H, Takagi T, Kajiyama T, Watanabe T, Igarashi M, Kusa S, Niida T, Iesaka Y, Furukawa T. Chromosome 4q25 variants and recurrence after second-generation cryoballoon ablation in patients with paroxysmal atrial fibrillation. Int. J. Cardiol. 2017, 244, 151-157. doi:10.1016/j.ijcard.2017.06.046.
  13. Ebana Y, Nitta J, Takahashi Y, Miyazaki S, Suzuki M, Liu L, Hirao K, Kanda E, Isobe M, Furukawa T. Association of the clinical and genetic factors with superior vena cava arrhythmogenicity in atrial fibrillation. Circ. J. 2017, 82, 71-77. doi:10.1253/circj.CJ-17-0350.
  14. Kawabata M, Goya M, Sasaki T, Maeda S, Shirai Y, Nishimura T, Yoshitake T, Shiohira S, Isobe M, Hirao K. Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy - Warfarin vs. Direct Oral Anticoagulants. Circ J. 2017 , 81, 645-651. doi:10.1253/circj.CJ-16-1089.
  15. Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H. Impact of creatinine clearance on outcomes in patients with non-valvular atrial. fibrillation: a subanalysis of the J-RHYTHM Registry. Eur Heart J Qual Care Clin Outcomes. 2018, 4, 59-68. doi:10.1093/ehjqcco/qcx032.
  16. Esato M, Chun YH, An Y, Ogawa H, Wada H, Hasegawa K, Tsuji H, Abe M, Lip GYH, Akao M. Clinical Impact of Asymptomatic Presentation Status in Patients with Paroxysmal and Sustained Atrial Fibrillation: The Fushimi AF Registry. Chest. 2017, 152, 1266-1275. doi:10.1016/j.chest.2017.08.004.
  17. Abe M, Ogawa H, Ishii M, Masunaga N, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Lip GY, Akao M. Relation of Stroke and Major Bleeding to Creatinine Clearance in Patients With Atrial Fibrillation (From the Fushimi AF Registry). Am J Cardiol. 2017, 119, 1229-1237. doi:10.1016/j.amjcard.2017.01.005. 
  18. Ogawa H, Senoo K, An Y, Shantsila A, Shantsila E, Lane DA, Wolff A, Akao M, Lip GYH. Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries. EBioMedicine. 2017, 18, 199-203. doi:10.1016/j.ebiom.2017.03.022.
  19. Yamashita Y, Uozumi R, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Ogawa H, Abe M, Morita S, Akao M. Current status and outcomes of direct oral anticoagulant use in patients with atrial fibrillation in the real-world: The Fushimi AF Registry. Circ J 2017, 81, 1278-1285. doi:10.1253/circj.CJ-16-1337.
  20. Ogawa H, Hamatani Y, Doi K, Tezuka Y, An Y, Ishii M, Iguchi M, Masunaga N, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GY, Akao M; Fushimi AF Registry Investigators. Sex-related differences in clinical events of patients with atrial fibrillation: The Fushimi AF Registry. Circ J 2017, 81, 1403-1410. doi:10.1253/circj.CJ-17-0071.
  21. Ishii M, Ogawa H, Unoki T, An Y, Iguchi M, Masunaga N, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Akao M. Relationship of hypertension and systolic blood pressure with the risk of stroke or bleeding in patients with atrial fibrillation: The Fushimi AF Registry. Am J Hypertens. 2017, 30, 1073-1082. doi:10.1093/ajh/hpx094.
  22. Sairenchi T, Iso H, Yamagishi K, Irie F, Nagao M, Umesawa M, Haruyama Y, Kobashi G, Watanabe H, Ota H. Impact and attribute of each obesity-related cardiovascular risk factor in combination with abdominal obesity on total health expenditures in adult Japanese National Health insurance beneficiaries: The Ibaraki Prefectural health study. J Epidemiol. 2017, 27, 354-359. doi:10.1016/j.je.2016.08.009.
  23. Ozawa M, Yoshida D, Hata J, Ohara T, Mukai N, Shibata M, Uchida K, Nagata M, Kitazono T, Kiyohara Y, Ninomiya T. Dietary protein intake and stroke risk in a general Japanese population: the Hisayama Study. Stroke. 2017, 48, 1478-1486. doi:10.1161/STROKEAHA.116.016059.
  24. Usui T, Nagata M, Hata J, Mukai N, Hirakawa Y, Yoshida D, Kishimoto H, Kitazono T, Kiyohara Y, Ninomiya T. Serum non-high-density lipoprotein cholesterol and risk of cardiovascular disease in community dwellers with chronic kidney disease: the Hisayama Study. J Atheroscler Thromb. 2017, 24, 706-15. doi:10.5551/jat.37044.
  25. Umehara K, Mukai N, Hata J, Hirakawa Y, Ohara T, Yoshida D, Kishimoto H, Kitazono T, Hoka S, Kiyohara Y, Ninomiya T. Association between serum vitamin D and all-cause and cause-specific death in a general Japanese population: the Hisayama Study. Circ J. 2017, 81, 1315-1321. doi:10.1253/circj.CJ-16-0954.
  26. Aizawa Y, Takatsuki S, Nishiyama T, Kimura T, Kohsaka S, Kaneko Y, Inden Y, Takahashi N, Nagase S, Aizawa Y, Fukuda K. Tachycardia-Induced J-Wave Changes in Patients With and Without Idiopathic Ventricular Fibrillation. Circ Arrhythm Electrophysiol. 2017, 10(7), pii: e005214. doi:10.1161/CIRCEP.117.005214.
  27. Watanabe E, Okajima K, Shimane A, Ozawa T, Manaka T, Morishima I, Asai T, Takagi M, Honda T, Kasai A, Fujii E, Yamashiro K, Kohno R, Abe H, Noda T, Kurita T, Watanabe S, Ohmori H, Nitta T, Aizawa Y, Kiyono K, Okumura K. Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing. J Interv Card Electrophysiol. 2017, 49, 271-280. doi:10.1007/s10840-017-0272-4.
  28. Aizawa Y, Nakayama M, Sato M, Okabe M, Aizawa Y, Takatsuki S, Fukuda K. "J waves" induced after short coupling intervals: a manifestations of latent depolarization abnormality? Europace. 2017, 15, 109-115. 2017 Apr 24.doi:10.1093/europace/eux062.
  29. Yamagata K, Horie M, Aiba T, Ogawa S, Aizawa Y, Ohe T, Yamagishi M, Makita N, Sakurada H, Tanaka T, Shimizu A, Hagiwara N, Kishi R, Nakano Y, Takagi M, Makiyama T, Ohno S, Fukuda K, Watanabe H, Morita H, Hayashi K, Kusano K, Kamakura S, Yasuda S, Ogawa H, Miyamoto Y, Kapplinger JD, Ackerman MJ, Shimizu W. Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry. Circ Arrhythm Electrophysiol. 2017, 135, 2255-2270. doi:10.1161/CIRCULATIONAHA.117.027983.
  30. Otuki S, Hasegawa K, Watanabe H, Katsuumi G, Yagihara N, Iijima K, Sato A, Izumi D, Furushima H, Chinushi M, Aizawa Y, Minamino T. The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias. J Electrocardiol. 2017, 50, 277-281. doi:10.1016/j.jelectrocard.2016.09.005.
  31. Kazawa S, Enomoto T, Suzuki N, Koshikawa T, Okubo Y, Yoshii S, Sato M, Okabe M, Yamashina A, Aizawa Y. Platypnea-orthodeoxia Syndrome in a Patient with an Atrial Septal Defect: The Diagnosis and Choice of Treatment. Intern Med. 2017, 56, 169-173. doi:10.2169/internalmedicine.56.7728.
  32. Aizawa Y. Catheter ablation of supraventricular tachycardia in d-transposition of the great arteries after corrective surgery. Heart Rhythm. 2017, 14, 357-358. doi:10.1016/j.hrthm.2016.12.024.
  33. Okumura K, Lip GYH, Akao M, Tanizawa K, Fukuzawa M, Abe K, Akishita M, Yamashita T. Edoxaban for the management of elderly Japanese patients with atrial fibrillation ineligible for standard oral anticoagulant therapies: Rationale and design of the ELDERCARE-AF study. Am Heart J. 2017, 194, 99-106. doi:10.1016/j.ahj.2017.08.017.
  34. Kumagai N, Nusser JA, Inoue H, Okumura K, Yamashita T, Kubo T, Kitaoka H, Origasa H, Atarashi H; J-RHYTHM Registry Investigators. Effect of addition of a statin to warfarin on thromboembolic events in japanese patients with nonvalvular atrial fibrillation and diabetes mellitus. Am J Cardiol. 2017, 120, 230-235. doi:10.1016/j.amjcard.2017.04.011.
  35. Chiang CE, Okumura K, Zhang S, Chao TF, Siu CW, Wei Lim T, Saxena A, Takahashi Y, Siong Teo W. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythm. 2017, 33, 345-367. doi:10.1016/j.joa.2017.05.004.
  36. Hata J, Fukuhara M, Sakata S, Arima H, Hirakawa Y, Yonemoto K, Mukai N, Kitazono T, Kiyohara Y, Ninomiya T. White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study. Hypertens Res. 2017, 40, 937-943. doi:10.1038/hr.2017.74.
  37. Sakata S, Hata J, Fukuhara M, Yonemoto K, Mukai N, Yoshida D, Kishimoto H, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T. Morning and evening blood pressures are associated with intima-media thickness in a general population: the Hisayama Study. Circ J. 2017, 81, 1647-1653. doi:10.1253/circj.CJ-16-1306.
  38. Kudo K, Hata J, Matsumoto K, Shundo Y, Fukuyama S, Inoue H, Kitazono T, Kiyohara Y, Ninomiya T, Nakanishi Y. Association of airflow limitation with carotid atherosclerosis in a japanese community: the Hisayama Study. Circ J. 2017, 81, 1846-1853. doi:10.1253/circj.CJ-16-1305.
  39. Oishi E, Ohara T, Sakata S, Fukuhara M, Hata J, Yoshida D, Shibata M, Ohtsubo T, Kitazono T, Kiyohara Y, Ninomiya T. Day-to-day blood pressure variability and risk of dementia in a general japanese elderly population: the Hisayama Study. Circulation. 2017, 136, 516-525. doi:10.1161/CIRCULATIONAHA.116.025667.
  40. Kokubo Y, Watanabe M, Higashiyama A, Nakao YM, Kusano K, Miyamoto Y. Development of a Basic Risk Score for Incident Atrial Fibrillation in a Japanese General Population - The Suita Study. Circ J. 2017, 25, 81, 1580-1588. doi:10.1253/circj.CJ-17-0277.
  41. Numao Y, Suzuki S, Arita T, Yagi N, Otsuka T, Sagara K, Semba H, Sasaki K, Kano H, Matsuno S, Kato Y, Uejima T, Oikawa Y, Nagashima K, Kirigaya H, Kunihara T, Yajima J, Aizawa T, Yamashita T. Predictors of international normalized ratio variability in patients with atrial fibrillation under warfarin therapy. Circ J 2017, 82, 39-45.
  42. Kamikubo Y, Inden Y, Nagao T, Aizawa Y, Murohara T. Different rate-dependent responses between J waves and the notches on an epicardial local electrogram in a patient with idiopathic ventricular fibrillation. Heart Rhythm Case Rep. 2017, 3, 427-430. doi:10.1016/j.hrcr.2017.06.010.
  43. Sato T, Aizawa Y, Yuasa S, Kishi S, Fuse K, Fujita S, Ikeda Y, Kitazawa H, Takahashi M, Sato M, Okabe M. The effect of dapagliflozin treatment on epicardial adipose tissue volume. Cardiovasc Diabetol. 2018, 17, 6. doi:10.1186/s12933-017-0658-8.
  44. 日本脳卒中学会 脳卒中医療向上・社会保険委員会「抗凝固療法中患者への脳梗塞急性期再開通治療に関する推奨」作業部会(部会長:豊田一則)「抗凝固療法中患者への脳梗塞急性期再開通治療に関する推奨 2017年11月」日本脳卒中学会HP(http://www.jsts.gr.jp/img/guideline20171222.pdf)、 脳卒中2018, 40, 123-135. doi:10.3995/jstroke.10597.
  45. リアルワールドを見極める3つのポイント,赤尾昌治,心電図. 2017, 37, 239-240. doi:10.5105/jse.37.239.
(2) 学会・シンポジウム等における口頭・ポスター発表
  1. 糖尿病合併心房細動患者における血糖コントロールと心不全入院リスクの関連性: 伏見AFレジストリより,ポスター,手塚祐司,村田敬,渡邊知一,井口守丈,小川尚,阿部充,江里正弘,全栄和,辻光,和田啓道,長谷川浩二,河野茂夫,山田和範,赤尾昌治,第60回日本糖尿病学会学術集会,2017/5/18,国内.
  2. 国民健康保険データベース解析による心房細動抗凝固療法の変遷:青森県津軽地域の現状,口頭(シンポジウム),富田泰史,成田憲紀,奥村謙,第4回 日本心血管脳卒中学会学術集会,2017/6/2,国内.
  3. わが国における心房細動のレジストリ研究,口頭(シンポジウム),赤尾昌治,第4回日本心血管脳卒中学会学術集会,2017/6/2,国内.
  4. 心房細動患者における心血管死と非心血管死の原因解析とリスク因子:Fushimi AF Registryから,口頭,安珍守,石井充,井口守丈,益永信豊,手塚祐司,土井康佑,江里正弘,全栄和,和田啓道,長谷川浩二,辻光,小川尚,阿部充,赤尾昌治,第4回日本心血管脳卒中学会学術集会,2017/6/3,国内.
  5. 脳卒中と大出血を既往にもつ心房細動患者の臨床的背景と予後~伏見心房細動患者登録研究より~,口頭,小川尚,土井康佑,手塚祐司,安珍守,石井充,井口守丈,益永信豊,江里正弘,全栄和,和田啓道,長谷川浩二,阿部充,赤尾昌治,第4回日本心血管脳卒中学会学術集会,2017/6/3,国内.
  6. Association of anemia with stroke/systemic embolism, bleeding, and cardiovascular death in patients with atrial fibrillation: The Fushimi AF Registry,ポスター,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Yuji Tezuka, Kohsuke Doi, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Hikari Tsuji, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017,Barcelona, Spain,2017/8/26,国外.
  7. Left ventricular concentric geometry has a prognostic value for ischemic stroke or systemic embolism in atrial fibrillation patients.: The Fushimi AF Registry,ポスター,Yuji Tezuka, Moritake Iguchi, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/26,国外.
  8. Evaluation of risk factors for major bleeding in AF patients with oral anticoagulation: The Fushimi AF Registry,ポスター,Mitsuru Ishii, Hisashi Ogawa, Nobutoyo Masunaga, Moritake Iguchi, Yoshimori An, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji, Hasegawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/27,国外.
  9. Comparison of characteristics and outcomes of atrial fibrillation patients undergoing coronary artery bypass grafting surgery and percutaneous coronary intervention: From the Fushimi AF Registry,ポスター,Nobutoyo Masunaga, Moritake Iguchi, Mitsuru Ishii, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji, Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/27,国外.
  10. Prevalence and mechanism of J waves in the middle- and high-aged subjects: with a special reference to patients after percutaneous coronary intervention,ポスター,Nakayama M, Goto S, Satomi K, Yuhara M, Goseki Y, Uchiyama T, Aizawa Y,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/27,国外.
  11. Association of body mass index with causes of death in patients with atrial fibrillation: The Fushimi AF Registry,ポスター,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Yuji Tezuka, Kohsuke Doi, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Hikari Tsuji, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/28,国外.
  12. Characteristics and outcomes in atrial fibrillation patients with previous thromboembolism and major bleeding: From the Fushimi AF Registry,ポスター,Hisashi Ogawa, Yuji Tezuka, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/28,国外.
  13. Predictive value of the CHA2DS2-VASc score for cardiovascular death in comparison with stroke in patients with atrial fibrillation: The Fushimi AF Registry,ポスター,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Yuji Tezuka, Kohsuke Doi, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Hikari Tsuji, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/29,国外.
  14. Prognostic effect of beta-blockers in patients with atrial fibrillation and heart failure: The Fushimi AF Registry,ポスター,Moritake Iguchi, Yuji Tezuka, Nobutoyo Masunaga, Mitsuru Ishii, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,European Society of Cardiology Congress 2017, Barcelona, Spain,2017/8/29,国外.
  15. Association of oral anticoagulant use with causes of death in Japanese patients with atrial Fibrillation: The Fushimi AF Registry,口頭,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Yuji Tezuka, Kousuke Doi, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/14,国内(国際学会).
  16. Progression from paroxysmal to sustained atrial fibrillation is associated with increased clinical outcomes: From the Fushimi AF Registry,口頭,Hisashi Ogawa, Yoshimori An, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/14,国内(国際学会).
  17. The Final Results of J-Dabigatran Surveillance Program: Safety and Effectiveness of Dabigatran Long-Term Treatment in Patients with Atrial Fibrillation Under Real Japanese Clinical Practice,口頭,Hiroshi Inoue, Shinichiro Uchiyama, Hirotsugu Atarashi, Ken Okumura, Yukihiro Koretsune, Masahiro Yasaka, Takeshi Yamashita, Taku Fukaya,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/14,国内(国際学会).
  18. Trend of oral anticoagulants by analysis using the “Kokuho Database” in patients with non-valvular atrial fibrillation in a Japanese local region,口頭,Narita N, Tomita H, Okumura K, The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/15,国内(国際学会).
  19. Impact of atrial fibrillation catheter ablation on the clinical outcome: The Fushimi AF Registry,口頭,Masahiro Esato, Yeong-Hwa Chun, Tetsuo Hashimoto, Mitsuru Abe, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/15,国内(国際学会).
  20. Different ECG Changes of CRBBB with Time between Health Check-up Examinees and Patients with Cardiac Diseases,口頭,Kazaway Y, Sato M, Kitazawa H, Okabe M, Aizawa Y,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/15, 国内(国際学会).
  21. Impact of Hypertrophic Cardiomyopathy on Predicting Thromboembolism or Death in Nonvalvular Atrial Fibrillation under Anticoagulant Therapy,口頭,Toyonobu TsudaKenshi Hayashi,Yoshihiro Tanaka,Akihiro Nomura,Yoji Nagata,Ryota Teramoto,Tetsuo Konno,Kenji Sakata,Noboru Fujino,Hiroshi Furusho,Masayuki Takamura,MasaAki Kawashiri,Masakazu Yamagishi,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/15,国内(国際学会).
  22. Addition of a Statin to Warfarin Reduced Thromboembolic Events in Japanese Patients with Non-valvular Atrial Fibrillation and Diabetes Mellitus,口頭,Naoko Kumagai, John A Nusser, Hiroshi Inoue, Ken Okumura, Takeshi Yamashita, Toru Kubo, Hiroaki Kitaoka, Hideki Origasa, Hirotsugu Atarashi,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/15 国内(国際学会).
  23. The First Experience of New Model of Insertable Cardiac Monitor for Japanese Patients: Data from the Reveal LINQ Registry,口頭(シンポジウム),Itsuro Morishima, Takanori Ikeda, Kengo Kusano, Ritsushi Kato, Hiroshi Morita, Kyoko Soejima, Erika Pouliot, Kazunori Toyoda, Ken Okumura,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/16 国内(国際学会).
  24. It Is Difficult to Maintain Stable Warfarin Control in Japanese Patients with Nonvalvular Atrial Fibrillation: A Subanalysis of J-Rhythm Registry,口頭,Hiroshi Inoue, Eitaro Kodani, Hirotsugu Atarashi, Ken Okumura, Takeshi Yamashita, Hideki Origasa,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/16 国内(国際学会).
  25. The 2017 Consensus of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation,口頭,Chern-En Chiang, Ken Okumura, Shu Zhang, Tze-Fan Chao, Chung-Wah Siu, Toon Wei Lim, Anil Saxena, Yoshihide Takahashi, Wee Siong Teo,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/17,国内(国際学会).
  26. Warfarin treatment is associated with reduced mortality in high CHADS2 score in Japanese patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry,口頭, Tomita H, Okumura K, Inoue H, Atarashi H, Yamashita T, Kodani E, Origasa H, on behalf of the J-RHYTHM Registry Investigators, The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/17,国内(国際学会).
  27. Optimal warfarin therapy in contemporary Japanese patients with atrial fibrillation. From the Japanese real world data,口頭,Kodani E, Inoue H, Atarashi H, Okumura K, Yamashita T, Tomita H, Origasa H. The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),Symposium (English),2017/9/17,国内(国際学会).
  28. Evaluation of Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Periproce-dural Period for Atrial Fibrillation Catheter Ablation. - The Results of Japanese Subgroup of RE-CIRCUIT Trial -,口頭(シンポジウム),Yukihiko Yoshida, Ken Okumura, Masato Watarai, Kenshi Fujii, Wataru Shimizu, Kazuhiro Satomi, Yasuya Inden, Yoshimasa Murakami, Masato Murakami, Atsushi Iwasa, Masaomi Kimura, Tomofumi Nakagawa, Matias Nordaby, on behalf of the Japanese investigators of RE-CIRCUIT trial,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/17 国内(国際学会).
  29. Report on Nationwide Survey of Catheter Ablation for Atrial Fibrillation in 2016: Japanese Catheter Ablation Registry for Atrial Fibrillation,口頭,Yuji Murakawa, Teiichi Yamane, Masahiko Goya, Koichi Inoue, Shigeto Naito, Koichiro Kumagai, Yasushi Miyauchi, Norishige Morita, Akihiko Nogami, Morio Shoda, Ken Okumura, Kenzo Hirao,The Joint Meeting of the 10th Asia Pacific Heart Rhythm Society Scientific Session (APHRS2017) and the 64th Annual Meeting of the Japanese Heart Rhythm Society (JHRS2017),2017/9/17,国内(国際学会).
  30. 慢性心房細動患者における心拍数の心血管イベントへの影響:伏見心房細動レジストリ,口頭,井口守丈,小川尚,杉山裕章,益永信豊,石井充,江里正弘,全栄和,和田啓道,長谷川浩二,阿部充,赤尾昌治,第65回日本心臓病学会学術集会,2017/10/1,国内.
  31. 日英における心房細動患者の男女差に関する検討,口頭,小川尚,妹尾恵太郎,安珍守,江里正弘,全栄和,土井康佑,石井充,井口守丈,益永信豊,中島康代,和田啓道,長谷川浩二,阿部充,Gregory Y H Lip,赤尾昌治,第65回日本心臓病学会学術集会,2017/10/1,国内.
  32. 動脈硬化性疾患を合併する心房細動患者の心血管イベントの発生について:伏見心房細動登録研究より,口頭,益永信豊,井口守丈,石井充,江里正弘,全栄和,和田啓道,長谷川浩二,小川尚,阿部充,赤尾昌治,第65回日本心臓病学会学術集会,2017/10/1,国内.
  33. Progression of heart failure is associated with higher mortality in patients with atrial fibrillation: The Fushimi AF Registry,口頭,Moritake Iguchi, Yuji Tezuka, Hisashi Ogawa, Nobutoyo Masunaga, Mitsuru Ishii, Yoshimori An, Kousuke Doi, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao,第21回日本心不全学会学術集会,2017/10/12-14,国内.
  34. Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: The Re-circuit study,
  35. Stefan H Hohnloser, Hugh Calkins, Stephan Willems, Atul Verma, Richard Schilling, Ken Okumura, Matias Nordaby, Edward P Gerstenfeld,American Heart Association Scientific Sessions 2017,2017/11,国外.
  36. Exploration of risk factors for major bleeding in AF patients without oral anticoagulation: The Fushimi AF Registry,,Mitsuru Ishii, Hisashi Ogawa, Nobutoyo Masunaga, Moritake Iguchi, Yoshimori An, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao. American Heart Association Scientific Sessions 2017,2017/11,国外.
  37. Risk factors for cardiovascular death in Japanese patients with atrial fibrillation: The Fushimi AF Registry,,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Kohsuke Doi, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,American Heart Association Scientific Sessions 2017,2017/11,国外.
  38. Characteristics and clinical outcomes in atrial fibrillation patients with valvular heart disease: The Fushimi AF Registry,Hisashi Ogawa, Kosuke Doi, Yoshimori An, Moritake Iguchi, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao. American Heart Association Scientific Sessions 2017,2017/11,国外.
  39. Relative Wall Thickness of the Left Ventricle Is an Independent Risk Factor of Stroke or Systemic Embolism in Patients with Atrial Fibrillation in Japan: The Fushimi AF Registry,Yuji Tezuka, Moritake Iguchi, Kousuke Doi, Yoshimori An, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Yeong-Hwa Chun, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao,American Heart Association Scientific Sessions 2017,2017/11,国外.
  40. 医療費シミュレーションツールの開発:茨城県健康研究,口頭,西連地利己,辻本健彦,須能恵子,入江ふじこ,渡辺宏,長尾匡則,梅澤光政,春山康夫,磯博康小橋元,大田仁史,第76回日本公衆衛生学会総会,2017/11/1,国内.
  41. Chronic kidney disease is a Risk factor for incidence atrial fibrillation in an urban Japanese population: The Suita Study,ポスター,Kokubo Y, Watanabe M, Higashiyama A, Nakao MY, Kusano K, Miyamoto Y. The International Society of Nephrology Frontiers Meeting 2018. Kidney Disease & Cardiovascular Disease,2018/2/25,国内.
  42. Is incidence of cardioembolic stroke decreasing? A possible effect of increasing prescription of direct oral anticoagulants,ポスター(英語), Noritomo Narita, Joji Hagii, Norifumi Metoki, Shin Saitoh, Minoru Yasujima, Ken Okumura, Hirofumi Tomita,第82回日本循環器病学会学術集会総会,2018/3/23-25,国内.
  43. B-type Natriuretic Peptides Levels as a Predictor of Atrial Fibrillation in a General Urban Population: The Suita Study,口頭,Kokubo Y, Watanabe M, Higashiyama A, Nakao MY, Nakamura F, Kusano K, Miyamoto Y,第82回日本循環器病学会学術集会総会,2018/3/23-25,国内.
  44. Oral Anticoagulant Therapy for Patients with Atrial Fibrillation Receiving Hemodialysis,口頭(シンポジウム),Masaharu Akao,第82回日本循環器病学会学術集会総会,2018/3/23-25,国内.
  45. Bleeding Complications in Patients with Atrial Fibrillation Receiving Anticoagulants: Up-to-Date,口頭(TOPIC),Masaharu Akao,第82回日本循環器病学会学術集会総会,2018/3/23-25,国内.
  46. Hypertension and the risk of adverse events in patients with atrial fibrillation: The Fushimi AF Registry,口頭(シンポジウム),Mitsuru Ishii, Hisashi Ogawa, Nobutoyo Masunaga, Moritake Iguchi, Yoshimori An, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji, Hasegawa, Mitsuru Abe, Masaharu Akao,第82回日本循環器病学会学術集会総会,2018/3/23-25,国内.
  47. The Incidence and Risk Factors of Percutaneous Coronary Intervention Procedures in Patients with Atrial Fibrillation: The Fushimi AF Registry,ポスター,Mitsuru Abe, Hisashi Ogawa, Syuhei Ikeda, Yuya Aono, Kosuke Doi, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/23,国内.
  48. Patient knowledge of atrial fibrillation and anticoagulant therapy: TASK-AF Fushimi pilot program,口頭,Masaharu Akao, Syuhei Ikeda, Yuya Aono, Kosuke Doi, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Hisashi Ogawa, Nobutoyo Masunaga, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe,第82回日本循環器病学会学術集会総会,2018/3/23,国内.
  49. Association between patient knowledge and treatment satisfaction in patients with atrial fibrillation receiving anticoagulant therapy: TASK-AF Fushimi pilot program,ポスター,Masaharu Akao, Syuhei Ikeda, Yuya Aono, Kosuke Doi, Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Hisashi Ogawa, Nobutoyo Masunaga, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe,第82回日本循環器病学会学術集会総会,2018/3/25,国内.
  50. Usefulness of the CHA2DS2-VASc Score in Predicting Stroke and Cardiovascular Death in Patients with Atrial Fibrillation: The Fushimi AF Registry,ポスター,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Kosuke Doi, Yuya Aono, Shuhei Ikeda, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao; for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/24,国内.
  51. Impact of Anemic Severity on Stroke/systemic Embolism, Bleeding, and Cardiovascular Death in Patients with Atrial Fibrillation: The Fushimi AF Registry,口頭,Yoshimori An, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Kosuke Doi, Yuya Aono, Shuhei Ikeda, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao; for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/25,国内.
  52. Clinical characteristics and outcomes of Japanese patients with valvular versus non-valvular atrial fibrillation: The Fushimi AF Registry,口頭,Kosuke Doi, Moritake Iguchi, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/23,国内.
  53. Cather ablation versus anti-arrhythmic drugs for atrial fibrillation rhythm-control therapy: A propensity score matched analysis from the Fushimi AF Registry,口頭,Masahiro Esato, Yoshimori An, Hiromichi Wada, Koji Hasegawa, Hikari Tsuji, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/24,国内.
  54. Risk factors of hospitalization for heart failure in patients with atrial fibrillation and pre-existing heart failure: The Fushimi AF Registry,口頭,Moritake Iguchi, Hisashi Ogawa, Nobutoyo Masunaga, Mitsuru Ishii, Yoshimori An, Kosuke Doi, Yuya Aono, Syuhei Ikeda, Masahiro Esato, Yeong-Hwa Chun, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/25,国内.
  55. Change of antithrombotic therapy in atrial fibrillation patients with combination therapy of oral anticoagulant and antiplatelet drug: The Fushimi AF registry,口頭,Nobutoyo Masunaga, Hisashi Ogawa, Moritake Iguchi, Mitsuru Ishii, Yoshimori An, Kosuke Doi, Yuya Aono, Shuhei Ikeda, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji, Hasegawa, Mitsuru Abe, Masaharu Akao,第82回日本循環器病学会学術集会総会,2018/3/24,国内.
  56. Clinical Outcomes of Atrial Fibrillation Patients with Bifascicular Block: The Fushimi AF Registry,口頭,Hisashi Ogawa, Hiroaki Sugiyama, Yoshimori An, Moritake Iguchi, Shuhei Ikeda, Yuya Aono, Kosuke Doi, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/23,国内.
  57. Clinical Characteristics and Prognosis of Atrial Fibrillation Patients with Fine Fibrillatory Wave: The Fushimi AF Registry,口頭,Hisashi Ogawa, Hiroaki Sugiyama, Yoshimori An, Syuhei Ikeda, Yuya Aono, Kosuke Doi, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/23,国内.
  58. Inappropriate Use of Direct Oral Anticoagulant is Associated with Increased Mortality Risk in Atrial Fibrillation Patients: The Fushimi AF Registry,口頭,Hisashi Ogawa, Yoshimori An, Shuhei Ikeda, Yuya Aono, Kosuke Doi, Mitsuru Ishii, Moritake Iguchi, Nobutoyo Masunaga, Masahiro Esato, Hikari Tsuji, Hiromichi Wada, Koji Hasegawa, Mitsuru Abe, Masaharu Akao, for the Fushimi AF Registry investigators,第82回日本循環器病学会学術集会総会,2018/3/24,国内.
  59. Risk factors for new-onset heart failure in atrial fibrillation patients without pre-existing organic heart disease: The Fushimi AF Registry,口頭,Yuya Aono, Moritake Iguchi, Syuhei Ikeda, Kosuke Doi, Yoshimori An, Mitsuru Ishii, Nobutoyo Masunaga, Masahiro Esato, Hiromichi Wada, Koji Hasegawa, Hisashi Ogawa, Mitsuru Abe, Masaharu Akao. 第82回日本循環器病学会学術集会総会,2018/3/23,国内.
  60. Impact of Hypertrophic Cardiomyopathy on Predicting Thromboembolism in Non-Valvular Atrial Fibrillation,口頭,Toyonobu Tsuda, Kenshi Hayashi, Tetsuo Konno, Akihiro Nomura, Yoshihiro Tanaka, Kenji Sakata, Noboru Fujino, Hiroshi Furusho, Masayuki Takamura, Masa-aki Kawashiri, Masakazu Yamagishi,第82回日本循環器学会学術集会,2018/3/24,国内.
  61. Cost and Benefit for Prevention of Thromboembolism in Non-valvular Atrial Fibrillation: Additional-analysis from the Hokuriku-plus AF registry,口頭,Toyonobu Tsuda, Kenshi Hayashi, Masakazu Yamagishi,第82回日本循環器学会学術集会,2018/3/24,国内.
  62. Impact of B-type natriuretic peptide level on the risk of thromboembolism and death in patients with nonvalvular atrial fibrillation: The Hokuriku-plus AF registory,口頭,Kenshi Hayashi, Toyonobu Tsuda, Akihiro Nomura, Kenji Sakata, Tetsuo Konno, Hayato Tada, Yoji Nagata, Ryota Teramoto, Yoshihiro Tanaka, Masa-aki Kawashiri, Noboru Fujino, Masakazu Yamagishi, on behalf of the Hokuriku-plus AF registry investigators,第82回日本循環器学会学術集会,2018/3/24,国内.
  63. Risk Factors for Thromboembolism in Low- and Moderate-risk Patients with Non-valvular Atrial Fibrillation. A Subanalysis of the J-RHYTHM Registry,口頭,Kodani E, Atarashi H, Inoue H, Tomita H, Okumura K, Yamashita T, Origasa H,第82回日本循環器学会学術集会,2018/3/24,国内.
  64. Renal Function and Time in Therapeutic Range in Anticoagulated, Elderly Patients with Nonvalvular Atrial Fibrillation: Subanalysis of J-RHYTHM Registry,口頭,Inoue H, Kodani E, Atarashi H, Okumura K, Yamashita T, Origasa H,第82回日本循環器学会学術集会,2018/3/24,国内.
  65. Difference in Quality-of-Life Between Atrial Fibrillation Patients with or without Family History: A Report from a Prospective Multicenter Outpatient Registry,口頭,藤澤大志, 木村雄弘, 池村修寛, 中嶋一晶, 勝俣良紀, 西山崇比古, 相澤義泰, 香坂俊, 秋間崇, 神吉秀明, 石川士郎, 永見圭一, 野間重孝, 髙月誠司, 福田恵一,第82回日本循環器学会学術集会,2018/3/24,国内.
  66. Temporal change in incidence of progression from paroxysmal to persistent atrial fibrillation in era of pulmonary vein isolation,口頭,Yagi N, Shinya Suzuki, Takuto Arita, Takayuki Otsuka, Hiroaki Senba, Hiroto Kanoh, Shunsuke Matsuno, Yuko Katoh, Tokuhisa Uejima, Yuji Oikawa, Kenichi Sasaki, Minoru Matsuhama, Takashi Kunihara, Junji Yajima, Takeshi Yamashita,第82回日本循環器学会学術集会,2018/3/24,国内.
  67. Gender difference in the impact of asymptomatic status on clinical outcomes in patients with atrial fibrillation,口頭,Arita T, Suzuki S, Yamashita T, et al,第82回日本循環器学会学術集会,2018/3/23,国内.
  68. Differences of treatment and prognosis by the experience of fall and/or bone fracture in elderly patients with atrial fibrillation,口頭,Akama J, Suzuki S, Yamashita T, et al,第82回日本循環器学会学術集会,2018/3/23,国内.
  69. Different Treatment and Prognosis by Mortality Risk in Elderly Patients with Atrial Fibrillation; A Retrospective Stratified Analysis in Shinken Database,口頭,Oita M, Suzuki S, Yamashita T, et al,第82回日本循環器学会学術集会,2018/3/25,国内.
  70. Comparison of Efficacy of Non Appropriate Low Doses among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation,ポスター,Takao Sato, Yoshifusa Aizawa, Naomasa Suzuki, Yuji Taya, Sho Yuasa, Shohei Kishi, Tomoyasu Koshikawa, Koichi Fuse, Satoshi Fujita, Yoshio Ikeda, Hitoshi Kitazawa, Minoru Takahashi, Masahito Sato, Masaaki Okabe,第82回日本循環器学会学術集会,2018/3/25,国内.
  71. Impact of Cancer on Major Bleeding and Stroke in Patients Using Novel Oral Anticoagulants,ポスター,Takao Sato, Yoshifusa Aizawa, Naomasa Suzuki, Yuji Taya, Sho Yuasa, Shohei Kishi, Tomoyasu Koshikawa, Koichi Fuse, Satoshi Fujita, Yoshio Ikeda, Hitoshi Kitazawa, Minoru Takahashi, Masahito Sato, Masaaki Okabe,第82回日本循環器学会学術集会,2018/3/24,国内.
  72. Novel Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease,ポスター,Takao Sato, Yoshifusa Aizawa, Naomasa Suzuki, Yuji Taya, Sho Yuasa, Shohei Kishi, Tomoyasu Koshikawa, Koichi Fuse, Satoshi Fujita, Yoshio Ikeda, Hitoshi Kitazawa, Minoru Takahashi, Masahito Sato, Masaaki Okabe,The 82th Annual Scientific Meeting of the Japanese Circulation Society,第82回日本循環器学会学術集会,2018/3/25,国内.
  73. Prevalence and mechanism of J waves in the middle- and high-aged subject: with a special reference to patients after percutaneous coronary intervention,ポスター,Nakayama M, Goto S, Satomi K, Yuhara M, Goseki Y, Uchiyama T, <u>Aizawa Y</u>,第82回日本循環器学会学術集会,2018/3/25,国内.